Latest Breaking News On - Anebulo pharmaceuticals inc - Page 1 : comparemela.com

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesRichie cunninghamCompany or anebuloSecurities exchangeDrug administrationUnited states department of justiceAmerica poison centersAnebulo pharmaceuticals incAnebulo pharmaceuticalsQuarter fiscal yearSubsequent highlightsUnited states departmentCentral nervous systemUnited states foodChief executive officerEmergency departments

Anebulo Pharmaceuticals, Inc (NASDAQ:ANEB) Sees Significant Drop in Short Interest

Anebulo Pharmaceuticals, Inc (NASDAQ:ANEB) Sees Significant Drop in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Anebulo pharmaceuticals incAnebulo pharmaceuticals stock performanceAnebulo pharmaceuticalsNews ratings for anebulo pharmaceuticals dailyGet free reportAnebulo pharmaceuticals daily

Anebulo Pharmaceuticals, Inc (NASDAQ:ANEB) Sees Significant Growth in Short Interest

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 4,600 shares, a growth of 39.4% from the February 29th total of 3,300 shares. Based on an average trading volume of 8,700 shares, the short-interest ratio […]

Vanguard group incAnebulo pharmaceuticalsAnebulo pharmaceuticals incAnebulo pharmaceuticals price performanceNews ratings for anebulo pharmaceuticals dailyExchange commissionGet free reportFree reportAnebulo pharmaceuticals dailyNasdaq aneb

Anebulo Pharmaceuticals, Inc (NASDAQ:ANEB) Short Interest Update

Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) was the recipient of a large increase in short interest in March. As of March 15th, there was short interest totalling 4,600 shares, an increase of 39.4% from the February 29th total of 3,300 shares. Approximately 0.1% of the shares of the company are sold short. Based […]

Anebulo pharmaceuticalsAnebulo pharmaceuticals incNews ratings for anebulo pharmaceuticals dailyAnebulo pharmaceuticals price performanceExchange commissionTower research capitalGet free reportResearch capitalFree reportAnebulo pharmaceuticals dailyNasdaq aneb

LVW Advisors LLC Sells 29,292 Shares of Anebulo Pharmaceuticals, Inc (NASDAQ:ANEB)

LVW Advisors LLC trimmed its stake in shares of Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Free Report) by 4.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 643,039 shares of the company’s stock after selling 29,292 shares during the quarter. LVW Advisors […]

News ratings for anebulo pharmaceuticals dailyAnebulo pharmaceuticals incAnebulo pharmaceuticals tradingExchange commissionLvw advisorsAnebulo pharmaceuticalsVanguard group incFree reportVanguard groupGet free reportAnebulo pharmaceuticals daily